| Patient | Benny Leonard |
|---|---|
| Date of birth | 1896-04-07 |
| Identifiers | MRN HR-BX008-SYN-TD; SSN (made up) 000-08-4106 |
| Document date | 1946-07-28 |
| Author | Miriam Okafor-Rosenthal, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit, and the recheck after last week's sick visit. [S]
Mr. Leonard, 50, comes for his yearly preventive visit, which also serves as the recheck one week after the sick visit. He drank as advised, the lightheadedness went within a day, his urine is pale and the cramps have stopped. He has not taken losartan-hydrochlorothiazide for a week, and his home readings have risen to about 142/88 mmHg. He has not refereed this week. He takes atorvastatin each evening without muscle aches. He wants to be back in the ring next week, and asks whether there is a blood pressure medicine that will not dry him out in the heat. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 50, with a recheck after volume depletion |
| Blood pressure | 142/88 mmHg in the clinic; home about 142/88 mmHg off treatment for a week |
| Kidney function | Creatinine 1.04 mg/dL, potassium 4.1 mmol/L, recovered |
| Cholesterol | LDL 66 mg/dL nine weeks after starting atorvastatin, from 160 |
| Mood | PHQ-2 1 |
Health risk assessment. Written questionnaire completed by the patient in the waiting room and reviewed with him by Dr. Okafor-Rosenthal. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good; better since his blood pressure was treated, apart from last week |
| Psychosocial | Many friends in boxing; worries about money less now that he is working full cards again |
| Tobacco | Never |
| Alcohol and drugs | A glass of wine on the Sabbath and holidays; AUDIT-C 2 at intake; no drugs |
| Physical activity | Walks to work and moves throughout fight nights; has started a brisk walk most mornings |
| Nutrition | Fewer deli meats and pickles; more fruit, vegetables and fish; eats earlier before fights |
| Sleep | Six to seven hours; late nights after fights |
| Driving and injury | Rides the subway or takes taxis; seat belt in cars |
| Home safety | Smoke alarm working; no firearms |
| Financial strain | Pays for his medicines; generic once-daily tablets are affordable; no food or housing insecurity |
| Dental | Dentist once a year |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, weight loss or fatigue now |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | Hears well; no mouth problems |
| Cardiovascular | Negative | No chest discomfort, lightheadedness, palpitations or ankle swelling |
| Respiratory | Negative | No breathlessness or cough |
| Gastrointestinal | Negative | No change in bowel habit or blood in the stool |
| Genitourinary | Negative | Urine pale; no urinary symptoms |
| Musculoskeletal | Negative | No muscle aches on atorvastatin; cramps gone |
| Integumentary | Negative | No new or changing skin spots |
| Neurological | Negative | No headache, weakness or numbness |
| Psychiatric | Negative | Mood good; PHQ-2 1 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Losartan 50 mg with hydrochlorothiazide 12.5 mg, one tablet each morning | One tablet each morning | Oral route | 1946-05-12 to 1946-06-30 | completed | S |
| Losartan 100 mg with hydrochlorothiazide 25 mg, one tablet each morning | One tablet each morning; held from the sick visit; stopped at the preventive visit | Oral route | 1946-06-30 to 1946-07-28 | stopped | S |
| Atorvastatin 40 mg tablet, one each evening | One tablet each evening | Oral route | 1946-05-26 | active | S |
| Losartan 100 mg tablet, one each morning | One tablet each morning; hold on sick days | Oral route | 1946-07-28 | active | S |
| Amlodipine 5 mg tablet, one each morning | One tablet each morning | Oral route | 1946-07-28 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1946-07-28 | Body height | 165 | cm | S |
| 1946-07-28 | Body weight | 73.6 | kg | S |
| 1946-07-28 | Body mass index (BMI) [Ratio] | 27 | kg/m2 | S |
| 1946-07-28 | Systolic blood pressure | 142 | mm[Hg] | S |
| 1946-07-28 | Diastolic blood pressure | 88 | mm[Hg] | S |
| 1946-07-28 | Heart rate | 72 | /min | S |
| 1946-07-28 | Respiratory rate | 14 | /min | S |
| 1946-07-28 | Body temperature | 36.6 | Cel | S |
| 1946-07-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1946-07-28 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-146 mmol/L | Normal | S |
| 1946-07-28 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 1946-07-28 | Urea nitrogen [Mass/volume] in Serum or Plasma | 17 | mg/dL | 7-25 mg/dL | Normal | S |
| 1946-07-28 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 1946-07-28 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1941)/1.73 sq M | 86 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1946-07-28 | Glucose [Mass/volume] in Serum or Plasma | 95 | mg/dL | 65-99 mg/dL | Normal | S |
| 1946-07-28 | Cholesterol [Mass/volume] in Serum or Plasma | 138 | mg/dL | <=199 mg/dL | Normal | S |
| 1946-07-28 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 47 | mg/dL | >=40 mg/dL | Normal | S |
| 1946-07-28 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 66 | mg/dL | <=99 mg/dL | Normal | S |
| 1946-07-28 | Triglyceride [Mass/volume] in Serum or Plasma | 124 | mg/dL | <=149 mg/dL | Normal | S |
| 1946-07-28 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S |
Vital signs recorded on 1946-07-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 73.6 kg, BMI 27.0; blood pressure 142/88 mmHg; pulse 72; no orthostatic fall |
| Eyes | Fundi with mild arteriolar narrowing; no hemorrhages or exudates |
| Cardiovascular | Regular rhythm; fourth heart sound; no murmur; no carotid bruit; foot pulses normal; no edema |
| Respiratory | Clear |
| Abdomen | Soft; no aortic pulsation felt |
| Skin | No lesions of concern |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness and tightness across the chest on exertion for about two months, late in long nights of refereeing in hot arenas, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling; cause under evaluation with a cardiology consultation | resolved | confirmed | R06.09 | S — Synthetic presenting problem anchored to his documented work as a referee; superseded at the consultation when stress testing showed no ischemia and the symptom was attributed to hypertensive heart disease. |
| Stage 2 hypertension found at a yearly fitness examination for his referee's license (164/100 and 160/98 mmHg), with left ventricular hypertrophy by voltage on the ECG; untreated; home readings to follow | resolved | confirmed | I10 | S — Synthetic diagnosis at intake; reclassified as hypertensive heart disease after the echocardiogram at the consultation. |
| Hypertensive heart disease without heart failure: concentric left ventricular hypertrophy (septum 13 mm, mass index 118 g/m2) with normal ejection fraction, grade 1 diastolic dysfunction, a mildly enlarged left atrium and an exaggerated blood pressure rise on exercise; no features of hypertrophic cardiomyopathy | active | confirmed | I11.9 | S — Synthetic diagnosis made at the cardiology consultation; not a claim about his real heart. |
| Coronary atherosclerosis found by coronary calcium scoring (Agatston score 186, about the 80th percentile for his age and sex), without angina and with no inducible ischemia on exercise stress echocardiography | active | confirmed | I25.10 | S — Synthetic diagnosis made at the cardiology consultation; not a retrospective diagnosis of the cause of his death, which is disputed. |
| Hypercholesterolemia: LDL 160 mg/dL, HDL 44 mg/dL, lipoprotein(a) not raised; no diabetes | active | confirmed | E78.00 | S — Synthetic diagnosis at intake. |
| Volume depletion after refereeing a long card in a heat wave while taking losartan 100 mg with hydrochlorothiazide 25 mg: lightheaded on standing, with an orthostatic fall in blood pressure, a prerenal rise in creatinine to 1.44 mg/dL and potassium 3.3 mmol/L; no fainting, chest pain or arrhythmia | resolved | confirmed | E86.0 | S — Synthetic acute problem from the thiazide in summer heat; not a historical claim. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 142/88 mmHg after a week off treatment; regimen changed |
| Lipids and statin | Completed today | LDL 66 mg/dL on atorvastatin 40 mg, from 160 |
| Prediabetes and type 2 diabetes screening | Up to date | HbA1c 5.5% at intake |
| Colorectal cancer screening | Ordered | Due from 45; he chose a yearly FIT; kit given today |
| Prostate cancer screening | Not indicated | PSA screening is an individual decision from 55 to 69; he is 50 with no known higher risk |
| Lung cancer screening | Not indicated | Never smoked |
| HIV screening | Completed today | Routine one-time screening for ages 15 to 65 |
| Hepatitis C screening | Completed today | One-time screening for all adults |
| Hepatitis B screening | Completed today | Triple panel, once for all adults |
| Depression screening | Completed today | PHQ-2 1; PHQ-9 5 at intake |
| Anxiety screening | Up to date | GAD-7 6 at intake, mild; repeat at six months |
| Unhealthy alcohol use | Up to date | AUDIT-C 2 at intake |
| Pneumococcal vaccine | Completed today | PCV20 today; no further dose needed |
| Zoster vaccine | Completed today | First recombinant dose today; second in two to six months |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap five years ago |
| Hepatitis B vaccine | Due | Recommended for all adults 19 to 59; given after the screening result if he is not immune |
| Influenza vaccine | Due | When this season's vaccine arrives in the autumn |
| COVID-19 vaccine | Due | In the autumn after discussion |
Immunizations given today: Pneumococcal conjugate vaccine PCV20, single dose, recommended for all adults 50 and older; Recombinant zoster vaccine, dose 1 of 2 [S]
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Colorectal Cancer: Screening (2021); Adult Immunization Schedule by Age (2026)
Follow-up: Fifteen-week review in four weeks with a basic metabolic panel. FIT kit by mail. Screening results by phone. Second zoster dose in two to six months; influenza and COVID-19 vaccines in the autumn. Next preventive visit in one year. Next scheduled visit 1946-08-25: fifteen-week review: blood pressure after the change of medicine, kidney function and potassium, cholesterol on the statin, and the sick visit. [S]
Voluntary discussion of about 15 minutes, with his consent. He named a health care agent, recorded in the chart and not named here, and completed a health care proxy form. He said he would want resuscitation and full treatment for any illness from which he could recover, and asked that his religious traditions be respected in hospital. The plan will be revisited every few years or after any serious illness. [S]